99mTc-MIBI scintigraphy of parathyroid adenomas and its relation to tumour size and oxyphil cell abundance
- 1. Dept. of Nuclear Medicine, Hasharon Hospital, Rabin Medical Center, Petah Tikva (Israel)
- 2. Dept. of Pathology, Hasharon Hospital, Rabin Medical Center, Petah Tikva (Israel)
- 3. Dept. of Oto-Rhino-Laryngology, Hasharon Hospital, Rabin Medical Center, Petah Tikva (Israel)
Description
The aim of this study was to assess the correlation between technetium-99m methoxyisobutylisonitrile (MIBI) uptake by parathyroid adenomas, oxyphil cell content and volume of the lesions. Thirty-one patients with parathyroid adenomas were evaluated prospectively. Preoperative double-phase 99mTc-MIBI scintigraphy was performed in all patients and tracer uptake by parathyroid lesions was assessed semi-quantitatively employing region of interest ratios to normal adjacent neck areas. Surgical specimens underwent histological evaluation and oxyphil cell content was determined. The intensity of tracer uptake was compared with oxyphil cell content, volume of the lesions and serum levels of calcium and parathormone. 99mTc-MIBI tracer uptake was correlated with oxyphil cell content, volume of parathyroid lesions and the functional status of the parathyroid adenomas. Tracer accumulation in oxyphil cells might partially explain the preferential 99mTc-MIBI retention in parathyroid lesions. (orig.)
Additional details
Publishing Information
- Journal Title
- European Journal of Nuclear Medicine
- Journal Volume
- 28
- Journal Issue
- 2
- Journal Page Range
- p. 209-213
- ISSN
- 0340-6997
- CODEN
- EJNMD9
INIS
- Country of Publication
- Germany
- Country of Input or Organization
- Germany
- INIS RN
- 32012101
- Subject category
- S62: RADIOLOGY AND NUCLEAR MEDICINE;
- Descriptors DEI
- ADENOMAS; DIAGNOSIS; ISONITRILES; PARATHORMONE; PARATHYROID GLANDS; PATIENTS; RADIOPHARMACEUTICALS; RETENTION; SCINTISCANNING; SIZE; TECHNETIUM 99; TECHNETIUM COMPLEXES; UPTAKE
- Descriptors DEC
- BETA DECAY RADIOISOTOPES; BETA-MINUS DECAY RADIOISOTOPES; BODY; CARBONIC ACID DERIVATIVES; CARCINOMAS; COMPLEXES; COUNTING TECHNIQUES; DIAGNOSTIC TECHNIQUES; DISEASES; DRUGS; ENDOCRINE GLANDS; GLANDS; HORMONES; HOURS LIVING RADIOISOTOPES; INTERMEDIATE MASS NUCLEI; INTERNAL CONVERSION RADIOISOTOPES; ISOMERIC TRANSITION ISOTOPES; ISOTOPES; LABELLED COMPOUNDS; MATERIALS; NEOPLASMS; NUCLEI; ODD-EVEN NUCLEI; ORGANIC COMPOUNDS; ORGANS; PEPTIDE HORMONES; PROTEINS; RADIOACTIVE MATERIALS; RADIOISOTOPE SCANNING; RADIOISOTOPES; TECHNETIUM ISOTOPES; TRANSITION ELEMENT COMPLEXES; YEARS LIVING RADIOISOTOPES